Ubiquitin-Conjugating Enzyme E2K (UBE2K) Peptide
Quick Overview for Ubiquitin-Conjugating Enzyme E2K (UBE2K) Peptide (ABIN938473)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- FTELRGEIAG PPDTPYEGGR YQLEIKIPET YPFNPPKVRF ITKIWHPNIS
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of UBE2 K antibody,
Alternative Names: UBE2K control peptide, UBE2K antibody Blocking Peptide, Anti-UBE2K Blocking Peptide, ubiquitin-conjugating enzyme E2K, UBC1 homolog, yeast Blocking Peptide, DKFZp564C1216 Blocking Peptide, DKFZp686J24237 Blocking Peptide, E2-25K Blocking Peptide, HIP2 Blocking Peptide, HYPG Blocking Peptide, LIG Blocking Peptide, UBE2K, UBEK-2, UBEK 2, UBEK-2 Blocking Peptide, UBEK 2 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- UBE2K (Ubiquitin-Conjugating Enzyme E2K (UBE2K))
-
Background
- UBE2K belongs to the ubiquitin-conjugating enzyme family. This protein interacts with RING finger proteins, and it can ubiquitinate huntingtin, the gene product for Huntington's disease. Known functions for this protein include a role in aggregate formation of expanded polyglutamine proteins and the suppression of apoptosis in polyglutamine diseases, a role in the dislocation of newly synthesized MHC class I heavy chains from the endoplasmic reticulum, and involvement in foam cell formation.
-
Molecular Weight
- 22 kDa
Target
-